Board and Governance Page

Governance Experience

Audit committee leadership, SEC compliance oversight, and shareholder alignment across public and venture-backed life sciences companies.

Seats

Board Seats.

AngioGenex

Oncology-focused biotechnology company

Board Director

AngioGenex

Oncology-focused biotechnology company

Board Director

SFA Therapeutics

Microbiome-based therapeutics for inflammatory and autoimmune conditions, including psoriasis, pancreatic cancer, and MASH/fibrosis.

Board Director

SFA Therapeutics

Microbiome-based therapeutics for inflammatory and autoimmune conditions, including psoriasis, pancreatic cancer, and MASH/fibrosis.

Board Director

GSNO Therapeutics

Focused on neurodegenerative and ophthalmic disease.

Board Director

GSNO Therapeutics

Focused on neurodegenerative and ophthalmic disease.

Board Director

Focus Areas

Governance Focus Areas.

Independent oversight built on three decades of financial leadership — from audit committee chairmanship to full board governance in regulated, publicly traded environments.

Audit Committee Leadership

01

Financial Reporting & Internal Controls

02

SEC Compliance

03

Shareholder Governance

04

Strategic Planning

05

Abstract patterns of blue ice inside a glacial cave.
Woman on pool float holding orange cup
People on beach watch vibrant sunset over ocean and island.
White sneakers and a red tote bag on green grass.
Woman meditating on yoga mat with phone and drink.
Woman knitting on couch with dog sleeping nearby
Audit Committee Leadership
Shareholder Governance
Financial Reporting & Internal Controls
SEC Compliance
Strategic Planning
Audit Committee Leadership

01

Financial Reporting & Internal Controls

02

SEC Compliance

03

Shareholder Governance

04

Strategic Planning

05

My unique value

Why Boards Bring me in.

Boards bring Robert in for capital markets depth built over three decades, independent judgment tested across public and private governance environments, and fluency in regulated industries — from SEC compliance to clinical-stage biotech oversight.

Boards bring Robert in for capital markets depth built over three decades, independent judgment tested across public and private governance environments, and fluency in regulated industries — from SEC compliance to clinical-stage biotech oversight.

  • ROBERT DICKEY

Managing Director at Foresite Advisors — he helps life sciences companies raise capital, navigate deals, and stay on solid financial footing — as a hands-on CFO advisor and as a board director.

© 2026 Robert Dickey IV. All rights reserved.

  • ROBERT DICKEY

Managing Director at Foresite Advisors — he helps life sciences companies raise capital, navigate deals, and stay on solid financial footing — as a hands-on CFO advisor and as a board director.

© 2026 Robert Dickey IV. All rights reserved.

  • ROBERT DICKEY

Managing Director at Foresite Advisors — he helps life sciences companies raise capital, navigate deals, and stay on solid financial footing — as a hands-on CFO advisor and as a board director.

© 2026 Robert Dickey IV. All rights reserved.